Skip to main content
. 2020 May 16;83(2):687–690. doi: 10.1016/j.jaad.2020.05.059

Table I.

Articles with more than 5 patients that described skin disease associated with presentation of COVID-19

Article Year and location Design Population Cases with cutaneous manifestations related to COVID-19 (%) Cutaneous manifestations Anatomic location of skin lesion Notes
Bouaziz et al4 2020; France Retrospective; multicenter 14 14 (100) Inflammatory lesions (7), vascular lesions (7) COVID-19 symptoms before skin lesion onset (14)
Duong et al5 2020; France Prospective; crowdsourced social media 295 295 (100) Chilblain-like lesion (146), other skin eruption (149)
Fernandez-Nieto et al6 2020; Spain Retrospective 346 132 (38.2) Chilblain-like lesion (95), erythema multiform–like lesion (37) Chilblain-like lesions (hand [33], feet [73]), erythema multiform–like lesions (hand [8], feet [35]) Skin lesion at COVID-19 symptom onset (3), COVID-19 symptoms before skin lesion onset (16); no diagnosis of pneumonia (132/132)
Galván Casas et al7 2020; Spain Prospective; crowdsourced survey 429 375 (87.4) Maculopapular lesion (176), urticarial lesion (73), pseudochilblain lesion (71), vesicular lesion (34), livedoid/necrotic lesion (21) Pseudochilblain (acral), vesicular (some trunk, limbs, diffuse), urticarial (mostly trunk or diffuse, few palmar), maculopapular (diffuse, few extremities), livedoid/necrotic (trunk, acral) Itch (213), pain (32), burning (22)
Landa et al8 2020; Spain Retrospective; multicenter 6 6 (100) Chilblain-like lesions (6) Foot (5), hand and foot (1) Pain (3), itch (2); skin lesion led to diagnosis of pneumonia (1)
Marzano et al9 2020; Italy Prospective; multicenter 22 22 (100) Varicella-like exanthem (22) Trunk (18), trunk and limbs (4) Itch (8), pain (2), burning (2), itch/burning (1); COVID-19 symptoms usually before skin findings
Piccolo et al10 2020; Italy Prospective; crowdsourced survey 63 63 (100) Chilblain-like lesions ([63: 54 had photos]; 31/54 erythematous-edematous, 23/54 blistering) Feet (86%), hands (6%), both (7%) Pain (27%), itch (27%), pain/itch (21%); most patients had lesions at diagnosis
Recalcati11 2020; Italy Prospective; single institution 88 18 (20.5) Erythematous rash (14), widespread urticaria (3), chicken pox–like vesicles (1) Trunk was most involved region Cutaneous manifestations at onset (8); cutaneous manifestation developed after hospitalization (10)
Recalcati et al12 2020; Italy Prospective; single institution 121 14 (11.6) Erythematoviolaceus acral rash, digital welling Feet (8), hands (4), hands and feet (2) Itch (3); children (11), young adults (3)

COVID-19, Coronavirus disease 2019.

Nonacral skin lesions excluded from counts per article methods.